Revenue, expenses and startup costs for medical marijuana dispensaries U.S. 2017

In the United States medical marijuana dispensaries can be divided into two types – regulated and unregulated. Among regulated dispensaries, the start-up costs for businesses launched in the past three years were about 775 thousand U.S. dollars as of 2017. Among non-regulated dispensaries, the start-up costs were lower at about 100 thousand U.S. dollars.The medical marijuana industry In some states the number of medical marijuana dispensaries in the U.S. is expected to increase in coming years to meet the demand for medical marijuana. Currently, California and Michigan have the largest number of medical marijuana patients in the United States. Meanwhile, Colorado and Ohio have the largest number of medical marijuana dispensaries among all U.S. states. The cannabidiol industry There are several cannabis-based products that comprise the total marijuana industry in the U.S. Recreational marijuana and hemp comprise the non-medical marijuana industry. Within the medical marijuana industry cannabidiol (CBD) is particularly interesting because it has huge medical potential without the psychoactive effects of tetrahydrocannabinol (THC). According to recent data, the CBD pharmaceutical industry in the U.S. is expected to grow dramatically in the coming years. Accordingly, regular non-medical adult use of CBD is also expected to increase in coming years.

在美国，医疗大麻零售店可分为两大类——受监管与未受监管。在受监管的零售店中，截至2017年，过去三年内新开业的企业启动成本约为77.5万美元。而在未受监管的零售店中，启动成本则相对较低，约为10万美元。预计在未来几年内，美国某些州的医疗大麻零售店数量将增加以满足医疗大麻的需求。目前，加利福尼亚州和密歇根州拥有美国最多的医疗大麻患者。与此同时，科罗拉多州和俄亥俄州是美国各州中拥有最多医疗大麻零售店的地方。在大麻产业中，包括休闲大麻和大麻 hemp 在内的非医疗大麻产业。在医疗大麻产业中，尤其是大麻二酚（CBD）因其具有巨大的医疗潜力且不含四氢大麻酚（THC）的成瘾效应而备受关注。根据最新数据，预计美国CBD制药产业在未来几年将显著增长。因此，非医疗成人对CBD的常规使用也预计将在未来几年增加。